• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨甲环酸用于治疗硬膜下血肿的应用

Usage of Tranexamic Acid for Treatment of Subdural Hematomas.

作者信息

Wu Michael, Wajeeh Hassaan, McPhail Marissa N, Seyam Omar, Flora Jamie, Nguyen Hoang

机构信息

Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.

Basic Sciences, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Clearwater, USA.

出版信息

Cureus. 2023 Apr 15;15(4):e37628. doi: 10.7759/cureus.37628. eCollection 2023 Apr.

DOI:10.7759/cureus.37628
PMID:37200656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10185923/
Abstract

The collection of blood in the subdural layer within the cranium is classified as a subdural hematoma. Prevalence of subdural hematomas is most common among older populations with the current standard of treatment being invasive surgical evacuation for patients presenting with acute subdural hematomas with a midline shift greater than 5 mm on computed tomography (CT).Tranexamic acid (TXA) has been identified as an alternative, non-invasive option to treat patients presenting with subdural hematoma who are not suitable for surgical intervention. The presenting case involves a 90-year-old female who arrived with a code stroke with the chief complaint of right lower extremity weakness. A stroke series CT panel revealed a left frontal multiloculated subdural hematoma, measuring 130 mL with mass effect and a midline shift of 7 mm. The patient was recommended a craniotomy for hematoma evacuation or access to hospice for comfort care. A second opinion resulted in the administration of TXA. After the full completion of a TXA course, the patient achieved baseline mobility. The final measurements revealed a final hematoma volume of 10 mL and a midline shift of less than 2 mm. Current literature, as well as the case described, has begun demonstrating the efficacy of the usage of TXA in the reabsorption of subdural hematomas and should encourage further exploration into society guidelines for the usage of TXA as a non-invasive alternative to treat subdural hematomas.

摘要

颅骨内硬膜下腔积血被归类为硬膜下血肿。硬膜下血肿在老年人群中最为常见,目前的治疗标准是对计算机断层扫描(CT)显示中线移位大于5mm的急性硬膜下血肿患者进行侵入性手术清除血肿。氨甲环酸(TXA)已被确定为治疗不适合手术干预的硬膜下血肿患者的一种非侵入性替代方法。本病例为一名90岁女性,因卒中代码入院,主要症状为右下肢无力。一系列卒中CT检查显示左额叶多房性硬膜下血肿,体积为130mL,有占位效应,中线移位7mm。建议患者进行开颅血肿清除术或入住临终关怀病房接受舒适护理。第二种意见是给予TXA治疗。在完成整个TXA疗程后,患者恢复到了基线活动能力。最终测量结果显示血肿最终体积为10mL,中线移位小于2mm。当前的文献以及所描述的病例已开始证明TXA在硬膜下血肿再吸收中的疗效,应鼓励进一步探索将TXA作为治疗硬膜下血肿的非侵入性替代方法纳入社会指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/3f60a8d8ea94/cureus-0015-00000037628-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/802dfdeb926a/cureus-0015-00000037628-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/b84d4e4c40e6/cureus-0015-00000037628-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/5e3be6f9e0b3/cureus-0015-00000037628-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/9b3bde406dee/cureus-0015-00000037628-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/3f60a8d8ea94/cureus-0015-00000037628-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/802dfdeb926a/cureus-0015-00000037628-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/b84d4e4c40e6/cureus-0015-00000037628-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/5e3be6f9e0b3/cureus-0015-00000037628-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/9b3bde406dee/cureus-0015-00000037628-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d1/10185923/3f60a8d8ea94/cureus-0015-00000037628-i05.jpg

相似文献

1
Usage of Tranexamic Acid for Treatment of Subdural Hematomas.氨甲环酸用于治疗硬膜下血肿的应用
Cureus. 2023 Apr 15;15(4):e37628. doi: 10.7759/cureus.37628. eCollection 2023 Apr.
2
Tranexamic Acid for Treatment of Residual Subdural Hematoma After Bedside Twist-Drill Evacuation.氨甲环酸用于床边锥颅引流术后残留硬膜下血肿的治疗。
World Neurosurg. 2016 Jul;91:29-33. doi: 10.1016/j.wneu.2016.03.062. Epub 2016 Mar 29.
3
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.氨甲环酸治疗慢性硬膜下血肿(TRACS):一项随机对照试验的研究方案
Trials. 2016 May 5;17(1):235. doi: 10.1186/s13063-016-1358-5.
4
Tranexamic Acid for Recurring Subdural Hematomas Following Surgical Evacuation: A Clinical Case Series.氨甲环酸用于手术清除后复发性硬膜下血肿:临床病例系列
J Neurol Surg A Cent Eur Neurosurg. 2016 Sep;77(5):422-6. doi: 10.1055/s-0036-1584212. Epub 2016 Jun 14.
5
Analysis of the subdural evacuating port system for the treatment of subacute and chronic subdural hematomas.分析硬脑膜下引流排出口系统治疗亚急性和慢性硬脑膜下血肿。
J Neurosurg. 2010 Nov;113(5):1004-10. doi: 10.3171/2010.5.JNS1083. Epub 2010 May 28.
6
The Outcome of Medical Management of Chronic Subdural Hematoma with Tranexamic Acid - A Prospective Observational Study.氨甲环酸治疗慢性硬膜下血肿的药物治疗效果——一项前瞻性观察研究
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105273. doi: 10.1016/j.jstrokecerebrovasdis.2020.105273. Epub 2020 Sep 4.
7
Tranexamic acid for chronic subdural hematoma.氨甲环酸用于慢性硬膜下血肿
Br J Neurosurg. 2021 Oct;35(5):564-569. doi: 10.1080/02688697.2021.1918328. Epub 2021 Aug 2.
8
Middle meningeal artery embolization before craniotomy for infected organizing chronic subdural hematoma: A case report and review of the literature.开颅手术治疗感染性机化慢性硬膜下血肿前的脑膜中动脉栓塞术:一例病例报告及文献复习
Surg Neurol Int. 2022 May 6;13:186. doi: 10.25259/SNI_73_2022. eCollection 2022.
9
The subdural evacuation port system: outcomes from a single institution experience and predictors of success.硬膜下引流端口系统:单机构经验的结果及成功的预测因素
Clin Neurol Neurosurg. 2013 Jun;115(6):658-64. doi: 10.1016/j.clineuro.2012.07.017. Epub 2012 Aug 3.
10
Predictors and Outcomes of Subdural Hematomas Managed via Subdural Evacuation Port System.经硬膜下引流端口系统治疗的硬膜下血肿的预测因素及预后
World Neurosurg X. 2022 Oct 5;17:100145. doi: 10.1016/j.wnsx.2022.100145. eCollection 2023 Jan.

引用本文的文献

1
A Case Report of Tranexamic Acid for the Treatment of Chronic Subdural Hematoma in an 86-Year-Old Patient.氨甲环酸治疗86岁患者慢性硬膜下血肿的病例报告
Cureus. 2024 Aug 14;16(8):e66846. doi: 10.7759/cureus.66846. eCollection 2024 Aug.
2
How artificial intelligence can provide information about subdural hematoma: Assessment of readability, reliability, and quality of ChatGPT, BARD, and perplexity responses.人工智能如何提供关于硬膜下血肿的信息:对ChatGPT、BARD和Perplexity回答的可读性、可靠性和质量评估。
Medicine (Baltimore). 2024 May 3;103(18):e38009. doi: 10.1097/MD.0000000000038009.
3
Navigating Choices: Determinants and Outcomes of Surgery Refusal in Thyroid Cancer Patients Using SEER Data.

本文引用的文献

1
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial.氨甲环酸预防慢性硬脑膜下血肿手术(TORCH):一项随机安慰剂对照临床试验的研究方案。
Trials. 2022 Jan 18;23(1):56. doi: 10.1186/s13063-021-05907-0.
2
The Outcome of Medical Management of Chronic Subdural Hematoma with Tranexamic Acid - A Prospective Observational Study.氨甲环酸治疗慢性硬膜下血肿的药物治疗效果——一项前瞻性观察研究
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105273. doi: 10.1016/j.jstrokecerebrovasdis.2020.105273. Epub 2020 Sep 4.
3
Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases.
选择的导航:利用监测、流行病学与结果(SEER)数据探究甲状腺癌患者拒绝手术的决定因素及后果
Cancers (Basel). 2023 Jul 20;15(14):3699. doi: 10.3390/cancers15143699.
老年非急性硬膜下血肿的脑膜中动脉栓塞治疗:151 例多机构经验。
Neurosurg Focus. 2020 Oct;49(4):E5. doi: 10.3171/2020.7.FOCUS20518.
4
Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome.慢性硬脑膜下血肿的最新研究进展:流行病学、病因学、发病机制、治疗和预后。
World Neurosurg. 2020 Sep;141:339-345. doi: 10.1016/j.wneu.2020.06.140. Epub 2020 Jun 25.
5
Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption.脑膜中动脉栓塞术作为手术治疗症状性慢性硬脑膜下血肿的辅助治疗:一项评估血肿体积吸收的初步研究。
J Neurointerv Surg. 2020 Jul;12(7):695-699. doi: 10.1136/neurintsurg-2019-015421. Epub 2019 Dec 20.
6
Spontaneous resolution of chronic subdural hematoma: Does only the size matter?慢性硬膜下血肿的自然消退:仅大小起作用吗?
Surg Neurol Int. 2019 Oct 4;10:194. doi: 10.25259/SNI_58_2019. eCollection 2019.
7
Expanding Subdural Hematomas in the Subacute Stage and Treatment via Catheter Drainage.亚急性期硬膜下血肿扩大及经导管引流治疗
Korean J Neurotrauma. 2018 Oct;14(2):76-79. doi: 10.13004/kjnt.2018.14.2.76. Epub 2018 Oct 31.
8
Conservative Treatment of Chronic Subdural Hematoma in HIV-Associated Thrombocytopenia with Tranexamic Acid.氨甲环酸对HIV相关性血小板减少症患者慢性硬膜下血肿的保守治疗
J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):211-214. doi: 10.1177/2325957416680294. Epub 2016 Dec 1.
9
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.氨甲环酸治疗慢性硬膜下血肿(TRACS):一项随机对照试验的研究方案
Trials. 2016 May 5;17(1):235. doi: 10.1186/s13063-016-1358-5.
10
Current diagnosis and treatment of chronic subdural haematomas.慢性硬膜下血肿的当前诊断与治疗
J Med Life. 2015 Jul-Sep;8(3):278-84.